Stay updated on LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial

Sign up to get notified when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T14:02:20.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH banner says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-24T13:41:35.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:43:41.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1. The study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T14:39:39.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The record history shows a new revision version, v3.7.0, has been added to replace the previous v3.6.6, signaling a page update to the study record.
    Difference
    0.1%
    Check dated 2026-09-19T17:46:47.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 has been added to the record history, replacing the previous v3.6.5 entry. This reflects the latest update to the ClinicalTrials.gov record for NCT01909453.
    Difference
    0.1%
    Check dated 2026-08-29T19:16:19.000Z thumbnail image

Stay in the know with updates to LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.